UniProt ID | BBS7_HUMAN | |
---|---|---|
UniProt AC | Q8IWZ6 | |
Protein Name | Bardet-Biedl syndrome 7 protein | |
Gene Name | BBS7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 715 | |
Subcellular Localization | Cell projection, cilium membrane . Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite . Cytoplasm, cytoskeleton, cilium basal body . | |
Protein Description | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization.. | |
Protein Sequence | MDLILNRMDYLQVGVTSQKTMKLIPASRHRATQKVVIGDHDGVVMCFGMKKGEAAAVFKTLPGPKIARLELGGVINTPQEKIFIAAASEIRGFTKRGKQFLSFETNLTESIKAMHISGSDLFLSASYIYNHYCDCKDQHYYLSGDKINDVICLPVERLSRITPVLACQDRVLRVLQGSDVMYAVEVPGPPTVLALHNGNGGDSGEDLLFGTSDGKLALIQITTSKPVRKWEIQNEKKRGGILCIDSFDIVGDGVKDLLVGRDDGMVEVYSFDNANEPVLRFDQMLSESVTSIQGGCVGKDSYDEIVVSTYSGWVTGLTTEPIHKESGPGEELKINQEMQNKISSLRNELEHLQYKVLQERENYQQSSQSSKAKSAVPSFGINDKFTLNKDDASYSLILEVQTAIDNVLIQSDVPIDLLDVDKNSAVVSFSSCDSESNDNFLLATYRCQADTTRLELKIRSIEGQYGTLQAYVTPRIQPKTCQVRQYHIKPLSLHQRTHFIDHDRPMNTLTLTGQFSFAEVHSWVVFCLPEVPEKPPAGECVTFYFQNTFLDTQLESTYRKGEGVFKSDNISTISILKDVLSKEATKRKINLNISYEINEVSVKHTLKLIHPKLEYQLLLAKKVQLIDALKELQIHEGNTNFLIPEYHCILEEADHLQEEYKKQPAHLERLYGMITDLFIDKFKFKGTNVKTKVPLLLEILDSYDQNALISFFDAA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLILNRM -------CCCHHHCC | 9.50 | 22814378 | |
19 (in isoform 1) | Ubiquitination | - | 50.80 | 21890473 | |
19 | Ubiquitination | QVGVTSQKTMKLIPA EECCCCHHHHCEECC | 50.80 | 22817900 | |
19 (in isoform 2) | Ubiquitination | - | 50.80 | 21890473 | |
22 | Ubiquitination | VTSQKTMKLIPASRH CCCHHHHCEECCCCC | 48.79 | 22817900 | |
32 | Phosphorylation | PASRHRATQKVVIGD CCCCCCCCCEEEEEC | 28.95 | 20058876 | |
50 | Ubiquitination | VVMCFGMKKGEAAAV EEEEEEECCCCEEEE | 58.99 | 22817900 | |
51 (in isoform 1) | Ubiquitination | - | 53.76 | 21890473 | |
51 | Ubiquitination | VMCFGMKKGEAAAVF EEEEEECCCCEEEEE | 53.76 | 21906983 | |
51 (in isoform 2) | Ubiquitination | - | 53.76 | 21890473 | |
59 | Ubiquitination | GEAAAVFKTLPGPKI CCEEEEEECCCCCEE | 42.42 | - | |
60 | Phosphorylation | EAAAVFKTLPGPKIA CEEEEEECCCCCEEE | 27.07 | 28060719 | |
65 | Ubiquitination | FKTLPGPKIARLELG EECCCCCEEEEEEEC | 55.71 | 29967540 | |
88 | Phosphorylation | KIFIAAASEIRGFTK HHHHHHHHHHCCCCH | 28.91 | - | |
126 | Phosphorylation | SDLFLSASYIYNHYC CCEEEEEHHHHHEEC | 14.53 | - | |
225 | Ubiquitination | LIQITTSKPVRKWEI EEEEECCCCCEEEEE | 45.50 | 27667366 | |
226 | Ubiquitination | IQITTSKPVRKWEIQ EEEECCCCCEEEEEC | 30.80 | 27667366 | |
240 | Ubiquitination | QNEKKRGGILCIDSF CCCCCCCCEEEEECC | 17.46 | 27667366 | |
241 | Ubiquitination | NEKKRGGILCIDSFD CCCCCCCEEEEECCE | 2.93 | 27667366 | |
246 | Phosphorylation | GGILCIDSFDIVGDG CCEEEEECCEECCCC | 12.61 | 26074081 | |
333 (in isoform 1) | Ubiquitination | - | 42.78 | 21890473 | |
333 | Ubiquitination | SGPGEELKINQEMQN CCCCCCCHHCHHHHH | 42.78 | 21906983 | |
333 (in isoform 2) | Ubiquitination | - | 42.78 | 21890473 | |
334 | Ubiquitination | GPGEELKINQEMQNK CCCCCCHHCHHHHHH | 11.41 | 22817900 | |
341 (in isoform 2) | Ubiquitination | - | 27.37 | 21890473 | |
341 | Ubiquitination | INQEMQNKISSLRNE HCHHHHHHHHHHHHH | 27.37 | 21906983 | |
341 (in isoform 1) | Ubiquitination | - | 27.37 | 21890473 | |
342 | Ubiquitination | NQEMQNKISSLRNEL CHHHHHHHHHHHHHH | 4.42 | 22817900 | |
343 | Phosphorylation | QEMQNKISSLRNELE HHHHHHHHHHHHHHH | 25.57 | 24719451 | |
344 | Phosphorylation | EMQNKISSLRNELEH HHHHHHHHHHHHHHH | 34.52 | 25954137 | |
348 | Ubiquitination | KISSLRNELEHLQYK HHHHHHHHHHHHHHH | 49.45 | 22817900 | |
349 | Ubiquitination | ISSLRNELEHLQYKV HHHHHHHHHHHHHHH | 6.00 | 22817900 | |
355 (in isoform 1) | Ubiquitination | - | 24.41 | 21890473 | |
355 (in isoform 2) | Ubiquitination | - | 24.41 | 21890473 | |
355 | Ubiquitination | ELEHLQYKVLQEREN HHHHHHHHHHHHHHH | 24.41 | 22817900 | |
356 | Ubiquitination | LEHLQYKVLQERENY HHHHHHHHHHHHHHH | 5.93 | 21890473 | |
357 | Ubiquitination | EHLQYKVLQERENYQ HHHHHHHHHHHHHHH | 3.71 | 22817900 | |
370 | Ubiquitination | YQQSSQSSKAKSAVP HHHCCCCHHHHHCCC | 29.06 | 21890473 | |
371 | Ubiquitination | QQSSQSSKAKSAVPS HHCCCCHHHHHCCCC | 66.15 | 21890473 | |
371 | Acetylation | QQSSQSSKAKSAVPS HHCCCCHHHHHCCCC | 66.15 | 25953088 | |
372 | Ubiquitination | QSSQSSKAKSAVPSF HCCCCHHHHHCCCCC | 17.00 | 27667366 | |
384 | Ubiquitination | PSFGINDKFTLNKDD CCCCCCCCEEECCCC | 35.44 | 29967540 | |
386 | Ubiquitination | FGINDKFTLNKDDAS CCCCCCEEECCCCCC | 34.85 | 27667366 | |
387 | Ubiquitination | GINDKFTLNKDDASY CCCCCEEECCCCCCE | 9.38 | 27667366 | |
457 | Ubiquitination | DTTRLELKIRSIEGQ CCCEEEEEEEEEECC | 27.05 | - | |
460 | Phosphorylation | RLELKIRSIEGQYGT EEEEEEEEEECCCEE | 28.59 | - | |
479 | Ubiquitination | VTPRIQPKTCQVRQY ECCCCCCCEEEEEEE | 45.62 | 27667366 | |
480 | Ubiquitination | TPRIQPKTCQVRQYH CCCCCCCEEEEEEEE | 18.17 | 27667366 | |
489 | Ubiquitination | QVRQYHIKPLSLHQR EEEEEEECCCCHHCC | 26.96 | - | |
494 | Ubiquitination | HIKPLSLHQRTHFID EECCCCHHCCCCCCC | 16.23 | 27667366 | |
495 | Ubiquitination | IKPLSLHQRTHFIDH ECCCCHHCCCCCCCC | 58.21 | 27667366 | |
522 | Ubiquitination | FSFAEVHSWVVFCLP CCHHEEEEEEEEECC | 27.09 | 22817900 | |
523 | Ubiquitination | SFAEVHSWVVFCLPE CHHEEEEEEEEECCC | 3.87 | 22817900 | |
527 | Ubiquitination | VHSWVVFCLPEVPEK EEEEEEEECCCCCCC | 4.13 | 22817900 | |
528 | Ubiquitination | HSWVVFCLPEVPEKP EEEEEEECCCCCCCC | 2.48 | 22817900 | |
531 | Ubiquitination | VVFCLPEVPEKPPAG EEEECCCCCCCCCCC | 7.58 | 22817900 | |
532 | Ubiquitination | VFCLPEVPEKPPAGE EEECCCCCCCCCCCC | 42.08 | 22817900 | |
538 | Ubiquitination | VPEKPPAGECVTFYF CCCCCCCCCEEEEEE | 34.31 | 22817900 | |
543 | Ubiquitination | PAGECVTFYFQNTFL CCCCEEEEEEECCCC | 2.61 | 22817900 | |
547 | Ubiquitination | CVTFYFQNTFLDTQL EEEEEEECCCCHHHH | 23.93 | 22817900 | |
567 | Phosphorylation | KGEGVFKSDNISTIS CCCCCCCCCCCCHHH | 25.15 | 22985185 | |
571 | Phosphorylation | VFKSDNISTISILKD CCCCCCCCHHHHHHH | 26.41 | 30622161 | |
572 | Phosphorylation | FKSDNISTISILKDV CCCCCCCHHHHHHHH | 18.23 | 30622161 | |
574 | Phosphorylation | SDNISTISILKDVLS CCCCCHHHHHHHHHC | 23.20 | 24719451 | |
577 (in isoform 2) | Ubiquitination | - | 44.09 | 21890473 | |
577 | Ubiquitination | ISTISILKDVLSKEA CCHHHHHHHHHCHHH | 44.09 | 21906983 | |
577 (in isoform 1) | Ubiquitination | - | 44.09 | 21890473 | |
578 | Ubiquitination | STISILKDVLSKEAT CHHHHHHHHHCHHHH | 43.05 | 22817900 | |
582 (in isoform 2) | Ubiquitination | - | 47.40 | 21890473 | |
582 (in isoform 1) | Ubiquitination | - | 47.40 | 21890473 | |
582 | Ubiquitination | ILKDVLSKEATKRKI HHHHHHCHHHHHCCE | 47.40 | 22817900 | |
583 | Ubiquitination | LKDVLSKEATKRKIN HHHHHCHHHHHCCEE | 59.19 | 22817900 | |
586 | Ubiquitination | VLSKEATKRKINLNI HHCHHHHHCCEEEEE | 59.76 | 22817900 | |
587 | Ubiquitination | LSKEATKRKINLNIS HCHHHHHCCEEEEEE | 40.51 | 22817900 | |
592 | Ubiquitination | TKRKINLNISYEINE HHCCEEEEEEEEECC | 19.37 | 22817900 | |
593 | Ubiquitination | KRKINLNISYEINEV HCCEEEEEEEEECCE | 5.38 | 22817900 | |
595 | Phosphorylation | KINLNISYEINEVSV CEEEEEEEEECCEEH | 19.61 | 25690035 | |
597 | Ubiquitination | NLNISYEINEVSVKH EEEEEEEECCEEHHE | 3.96 | 22817900 | |
598 | Ubiquitination | LNISYEINEVSVKHT EEEEEEECCEEHHEE | 31.51 | 22817900 | |
601 | Ubiquitination | SYEINEVSVKHTLKL EEEECCEEHHEEHHH | 21.19 | 22817900 | |
601 | Phosphorylation | SYEINEVSVKHTLKL EEEECCEEHHEEHHH | 21.19 | 25690035 | |
602 | Ubiquitination | YEINEVSVKHTLKLI EEECCEEHHEEHHHH | 6.77 | 22817900 | |
615 | Phosphorylation | LIHPKLEYQLLLAKK HHCCHHHHHHHHHHH | 18.20 | 19664994 | |
621 | Acetylation | EYQLLLAKKVQLIDA HHHHHHHHHHHHHHH | 54.14 | 164225 | |
622 | Ubiquitination | YQLLLAKKVQLIDAL HHHHHHHHHHHHHHH | 29.61 | - | |
622 | Acetylation | YQLLLAKKVQLIDAL HHHHHHHHHHHHHHH | 29.61 | 164221 | |
662 | Ubiquitination | HLQEEYKKQPAHLER HHHHHHHHCHHHHHH | 61.69 | 29967540 | |
675 | Phosphorylation | ERLYGMITDLFIDKF HHHHHHHHHHHHHHC | 20.11 | 27732954 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BBS7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BBS7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BBS7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00418 | Bardet-Biedl syndrome (BBS) | |||||
OMIM Disease | ||||||
Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. Single-locus allelism is insufficient to explain the variable penetrance and expressivity of such disorders, leading to the suggestion that variations across multiple sites of the ciliary proteome, including BBS7, influence the clinical outcome. | ||||||
615984 | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...